Buy Carbolieva 150mg Injection USA – Ernest Oncology Exporter from India

Comprehensive Guide to Carbolieva 150mg Injection: Global Export & Distribution by Ernest Oncology

At Ernest Oncology (a division of Ernest Pharmaceutical Pvt. Ltd.), we are an internationally recognized exporter, bulk supplier, and distributor of critical oncology formulations. We specialize in the secure, compliant, and efficient supply of Carbolieva 150mg Injection (Carboplatin Injection 150mg/15mL) to healthcare providers, hospitals, and pharmaceutical distributors worldwide, with targeted delivery networks in the USA, UK, Australia, and South Africa.

This comprehensive guide covers the medical profile, mechanisms, uses, and an extensive list of SEO keywords designed to boost the online visibility of B2B pharmaceutical suppliers.

1. Product Information: Carbolieva 150mg Injection

Carbolieva 150mg Injection contains Carboplatin, which is a platinum-based antineoplastic agent. It is utilized for its antineoplastic effects against various solid tumors, providing a favorable toxicity profile compared to older platinum-containing compounds.

Key Product Details

• Composition: Carboplatin 150 mg / 15 mL (10 mg/mL).

• Therapeutic Class: Platinum coordination complex / Alkylating agent.

• Formulation Type: Intravenous infusion solution.

• Storage Temperature: Store below 25°C. Protect from light. Do not freeze.

2. Mechanism of Action

Carbolieva functions as an alkylating agent that interferes with the genetic material of cancer cells:

• DNA Cross-linking: The compound enters the cell and binds to DNA, forming intra-strand and inter-strand cross-links.

• Inhibition of Synthesis: This cross-linking inhibits DNA replication and transcription.

• Apoptosis: The resulting DNA damage triggers programmed cell death (apoptosis) in rapidly dividing malignant cells.

3. Therapeutic Indications and Uses

Carbolieva 150mg Injection is indicated for:

• Ovarian Cancer: First-line and adjunctive therapy for advanced ovarian carcinoma.

• Small Cell Lung Cancer (SCLC): Used in combination regimens for treating extensive or limited-stage SCLC.

• Other Solid Tumors: Off-label and secondary treatments for cervical, bladder, and head/neck cancers.

4. Administration and Safety Warnings

Administration

• Route of Administration: Intravenous (IV) infusion (usually over 15 to 60 minutes) after dilution in 5% Dextrose or Normal Saline.

• Dosage Formulation: Administered under the direct supervision of an oncologist, with dosage typically calculated based on the Calvert formula (using renal function and body surface area).

Side Effects & Precautions

• Common Side Effects: Nausea, vomiting, fatigue, loss of appetite, and alopecia (hair loss).

• Serious Risks: Severe bone marrow suppression (leading to thrombocytopenia, neutropenia, and anemia), nephrotoxicity (kidney damage), ototoxicity, and peripheral neuropathy.

• Contraindications: Hypersensitivity to platinum-containing compounds, severe bone marrow depression, and active bleeding tumors.